New targets for triple-negative breast cancer

Oncology (Williston Park, N.Y.)

Volumn 27, Issue 9, 2013, Pages 846-854

  Herold, Christina I ^a   Anders, Carey K ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOMICS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PHENOTYPE; PROGNOSIS; SIGNAL TRANSDUCTION; TRANSLATIONAL RESEARCH; TRIPLE NEGATIVE BREAST NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DESIGN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; MOLECULAR TARGETED THERAPY; PHENOTYPE; PROGNOSIS; SIGNAL TRANSDUCTION; TRANSLATIONAL MEDICAL RESEARCH; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84891645183     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)